Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol

NANot yet recruitingINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

December 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Type 2 Diabetes (T2DM)Glycemic ControlDiabetes KnowledgeMedication AdherenceQuality of Life
Interventions
BEHAVIORAL

PharmaTE Trial

In addition to standard care, patients in the PharmaTE trial interventional group will receive tele-education led by a clinical pharmacist who has completed a training course and is certified as a diabetes educator. The tele-education program is comprised of five individualized educational sessions, each lasting approximately 20-30minutes and held at two-month intervals. These sessions are conducted via Zoom or telephone based on patient preference. Before the beginning of each session, participants will receive a reminder message along with the Zoom meeting invitation link about the session, covering various educational topics related to diabetes management. Additionally, after each session, patients will receive a brochure summarizing what has been discussed.

All Listed Sponsors
collaborator

Universiti Sains Malaysia

OTHER

lead

Rabia Hussain

OTHER